AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 24773915
Drug: Topical cream
RxNorm normalized name: Topical Cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical cream delivering narrow-band ultraviolet B, average of 38 sessions
Trial: 20353858
Drug: Collagenase injection
DrugBank: Collagenase clostridium histolyticum (DB00048)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Collagenase injection for MCP joint contracture
Trial: 20353858
Drug: Collagenase injection
DrugBank: Collagenase clostridium histolyticum (DB00048)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Collagenase injection for PIP joint contracture
Trial: 20353858
Drug: Initial response
RxNorm normalized name: Besponsa
DrugBank: Inotuzumab ozogamicin (DB05889)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Initial response to collagenase injection
Trial: 18561583
Drug: Solubilized BPO
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Solubilized BPO 5% gel
Trial: 18561583
Drug: BPO 5%/clindamycin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BPO 5%/clindamycin 1% combination product
Trial: 14759375
Drug: Low-dose alteplase
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose alteplase (50 mg) and tirofiban (0.4 microg/kg/min/30 minute bolus; infusion of 0.1 microg/kg/minute)
Trial: 14759375
Drug: Standard strategy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard strategy with either full-dose alteplase (100 mg) or stenting PCI
Trial: 7688432
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg pentosanpolysulfate 3 times per day
Trial: 3523457
Drug: Ceftazidime (CZ)
RxNorm normalized name: Ceftazidime
DrugBank: Ceftazidime (DB00438)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ceftazidime (CZ) at a dose of 150 mg/kg/day divided every 8 hours
Trial: 3523457
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment with chloramphenicol and ampicillin (CA)
Trial: 29316962
Drug: Control (standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (standard care with antibiotics and chlorhexidine mouthwash)
Trial: 18417739
Drug: Tipifarnib administered
RxNorm normalized name: Tipifarnib
DrugBank: Tipifarnib (DB04960)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tipifarnib administered concurrently with radiation therapy at dose levels ranging from 100 to 150 mg/m(2)/dose, followed by adjuvant tipifarnib at 200 mg/m(2)/dose for 21 consecutive days in 28-day cycles.
Trial: 15923005
Drug: Early oral
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early oral feeding (8 h)
Trial: 15923005
Drug: Delayed oral
RxNorm normalized name: lipase 12,000 UNT / amylase 39,000 UNT / protease 39,000 UNT Delayed Oral Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed oral feeding (24 h)
Trial: 12534646
Drug: Amprenavir 600
RxNorm normalized name: Lexiva (as fosamprenavir calcium) 700 MG (amprenavir 600 MG) Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amprenavir 600 mg twice a day for 10 days
Trial: 12534646
Drug: Delavirdine 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delavirdine 600 mg twice a day for 10 days
Trial: 11244724
Drug: Amantadine hydrochloride
RxNorm normalized name: Amantadine Hydrochloride
DrugBank: Amantadine (DB00915)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amantadine hydrochloride 100 mg/d
Trial: 11244724
Drug: Control (ordinary
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (ordinary medication only)
Trial: 9253881
Drug: Mebendazole (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mebendazole (400 mg single dose)
Trial: 21666432
Drug: Donepezil (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Donepezil (5 mg/d) for 6 months
Trial: 19725485
Drug: Corticosteroid injection
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroid injection with lidocaine
Trial: 15056486
Drug: Atypical antipsychotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atypical antipsychotic treatment over 14 weeks
Trial: 15056486
Drug: Atypical antipsychotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atypical antipsychotic treatment
Trial: 2820626
Drug: CGS 14824A
RxNorm normalized name: Alkamide 101-cg
DrugBank: Coco diethanolamide (DB18828)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CGS 14824A (2 mg p.o. q.d.)
Trial: 2820626
Drug: CGS 14824A
RxNorm normalized name: Alkamide 101-cg
DrugBank: Coco diethanolamide (DB18828)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CGS 14824A (10 mg p.o. q.d.)
Trial: 27435610
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment (transcutaneous electrical stimulation)
Trial: 27435610
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment (transcutaneous electrical stimulation) in mild-to-moderate OSA subgroup
Trial: 17853277
Drug: Quetiapine 300
RxNorm normalized name: quetiapine 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quetiapine 300 mg/day and 600 mg/day
Trial: 16027809
Drug: Preparation of
RxNorm normalized name: kit for the preparation of Ga-68
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preparation of polyunsaturated phospholipids (lipostabil forte)
Trial: 10466877
Drug: Omeprazole (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole (40 mg daily for 10 days)
Trial: 442014
Drug: D‐ASA (Dipyridamole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D‐ASA (Dipyridamole 30 mg and ASA 300 mg administered intravenously two hours before surgery, then orally three times a day in tablets containing dipyridamole 50 mg and ASA 330 mg)
Trial: 442014
Drug: Low doses
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low doses of Heparin (5000 IU subcutaneously twice a day starting two hours pre-operatively)
Trial: 11710409
Drug: Sodium citrate
RxNorm normalized name: Sodium Citrate
DrugBank: Sodium nitrate (DB15952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium citrate (0.5 g x kg(-1) body mass)
Trial: 11710409
Drug: NaCl (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NaCl (0.1 g x kg(-1) body mass)
Trial: 9205017
Drug: Atorvastatin 10
RxNorm normalized name: atorvastatin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 10 mg, titrated to 20 mg if needed
Trial: 9205017
Drug: Simvastatin 10
RxNorm normalized name: simvastatin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin 10 mg, titrated to 20 mg if needed
Trial: 30334639
Drug: Verinurad 5
RxNorm normalized name: Verinurad
DrugBank: Verinurad (DB11873)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verinurad 5 mg
Trial: 30334639
Drug: Verinurad 12.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verinurad 12.5 mg
Trial: 29688628
Drug: Verinurad 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verinurad 2.5 mg
Trial: 21831359
Drug: Paliperidone ER
RxNorm normalized name: Paliperidone ER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paliperidone ER Medium (3 mg)
Trial: 21831359
Drug: Paliperidone ER
RxNorm normalized name: Paliperidone ER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paliperidone ER Low (1.5 mg)
Trial: 21831359
Drug: Paliperidone ER
RxNorm normalized name: Paliperidone ER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paliperidone ER High (6 mg)
Trial: 21831359
Drug: Paliperidone ER
RxNorm normalized name: Paliperidone ER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paliperidone ER (3 mg)
Trial: 21831359
Drug: Paliperidone ER
RxNorm normalized name: Paliperidone ER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paliperidone ER (12 mg)
Trial: 17676687
Drug: 10 weekly
RxNorm normalized name: donepezil
DrugBank: Donepezil (DB00843)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 10 weekly group CBT sessions
Trial: 28991664
Drug: Standard rehabilitation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard rehabilitation treatment (control group)
Trial: 21869712
Drug: Triamcinolone hexacetonide
RxNorm normalized name: Triamcinolone Hexacetonide
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Triamcinolone hexacetonide (TAH) 20 mg
Trial: 18543492
Drug: Chemotherapy (NP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy (NP or GP protocol)
Trial: 18543492
Drug: YYJD and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: YYJD and chemotherapy in combination
Trial: 14692211
Drug: Colgate Cavity
RxNorm normalized name: DELTA COMFORT PLUS 2019 AMENITY With Colgate Cavity Protection KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colgate Cavity Protection Winterfresh Gel (0.243% sodium fluoride)
Trial: 8465010
Drug: Pre‐ or
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pre‐ or postoperative megavoltage radiation therapy (45 Gy/5 weeks)
Trial: 8465010
Drug: Pre‐ or
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pre‐ or postoperative megavoltage radiation therapy
Trial: 25227114
Drug: Early goal-directed
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Early goal-directed therapy using arterial waveform analysis
Trial: 20144066
Drug: Benidipine (4-8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benidipine (4-8 mg/day) combined with olmesartan (10 mg/day)
Trial: 20144066
Drug: Amlodipine (5-10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine (5-10 mg/day) combined with olmesartan (10 mg/day)
Trial: 11213073
Drug: 2 mg/day
RxNorm normalized name: Neupro 2 MG/Day 24 HR Transdermal Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg/day sirolimus
Trial: 11213073
Drug: 5 mg/day
RxNorm normalized name: Lyllana 0.05 MG/Day Transdermal Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg/day sirolimus
Trial: 9627862
Drug: Ibuprofen (800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen (800 mg 3 times a day for 1 week, 800 mg twice a day for 1 week, and 800 mg as needed to a maximum daily dose of 2400 mg for 7 weeks) and nocturnal wrist supports
Trial: 9627862
Drug: Chiropractic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chiropractic treatment (manipulation of soft tissues and bony joints of the upper extremities and spine, ultrasound over the carpal tunnel, and nocturnal wrist supports)
Trial: 7877194
Drug: Captopril (37.5-75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril (37.5-75 mg/d)
Trial: 7877194
Drug: Nadolol (40-80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nadolol (40-80 mg/d)
Trial: 3048092
Drug: Cefixime (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefixime (400 mg once daily)
Trial: 3048092
Drug: Amoxicillin (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin (250 or 500 mg three times daily)
Trial: 28080323
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg of ATP as disodium salt
Trial: 17163255
Drug: Paracetamol 1g
DrugBank: Acetaminophen (DB00316)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Paracetamol 1g plus ciprofloxacin 500mg
Trial: 9322521
Drug: Naltrexone (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naltrexone (50 mg daily for 4 weeks)
Trial: 4056256
Drug: Nifedipine aerosol,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine aerosol, 10 mg in 40% ethanol
Trial: 22747856
Drug: Drug lymphocyte
RxNorm normalized name: lymphocyte immune globulin, anti-thymocyte globulin Injection [ATGAM]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug lymphocyte stimulation test (DLST) performed at Week 1 of adverse reactions
Trial: 22747856
Drug: Drug lymphocyte
RxNorm normalized name: lymphocyte immune globulin, anti-thymocyte globulin Injection [ATGAM]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug lymphocyte stimulation test (DLST) performed 2 months after the reaction (Group A)
Trial: 22747856
Drug: Drug lymphocyte
RxNorm normalized name: lymphocyte immune globulin, anti-thymocyte globulin Injection [ATGAM]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug lymphocyte stimulation test (DLST) performed >12 months after the reaction (Group B)
Trial: 18768511
Drug: MTHFR 1298
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MTHFR 1298 CC genotype
Trial: 12456031
Drug: 6% hydroxy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6% hydroxy ethyl starch solution (10 ml/kg, 30 minutes)
Trial: 12456031
Drug: FPSA treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FPSA treatment
Trial: 8534744
Drug: Dialysis solution
RxNorm normalized name: dialysis solutions
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dialysis solution at a sodium concentration of 126 mEq/L (low sodium)
Trial: 8534744
Drug: Dialysis solution
RxNorm normalized name: dialysis solutions
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dialysis solution at a sodium concentration of 132 mEq/L (normal sodium)
Trial: 2014078
Drug: Amnioinfusion with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amnioinfusion with warmed saline solution
Trial: 6517242
Drug: Amezinium methylsulfate
RxNorm normalized name: amezinium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amezinium methylsulfate 5 mg i.v. given if blood pressure dropped greater than 20 mmHg
Trial: 24238984
Drug: No helmet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No helmet therapy (control)
Trial: 22441566
Drug: Cetuximab-based treatment
RxNorm normalized name: Cetuximab
DrugBank: Cetuximab (DB00002)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Cetuximab-based treatment
Trial: 22441566
Drug: Bevacizumab-based treatment
RxNorm normalized name: Bevacizumab
DrugBank: Bevacizumab (DB00112)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Bevacizumab-based treatment
Trial: 20008831
Drug: Mipomersen 200
RxNorm normalized name: mipomersen 200 mg/mL subcutaneous solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mipomersen 200 mg weekly for 13 weeks
Trial: 17413113
Drug: Vegetable group
RxNorm normalized name: Hydrogenated Vegetable Oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vegetable group (5.6 mg beta-carotene/d from green leafy vegetables)
Trial: 17413113
Drug: Fruit group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fruit group (4.8 mg beta-carotene/d from orange or yellow fruit)
Trial: 17413113
Drug: Retinol-rich group
RxNorm normalized name: retinol
DrugBank: Vitamin A (DB00162)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Retinol-rich group (610 microg retinol/d from animal foods and 0.6 mg beta-carotene/d)
Trial: 17413113
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (0.4 mg beta-carotene/d)
Trial: 11115437
Drug: Oral prednisone
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral prednisone 10 mg qd
Trial: 9363727
Drug: Pentoxifylline (800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pentoxifylline (800 mg/day for 12 months)
Trial: 1543782
Drug: Peritoneal dialysis
RxNorm normalized name: Peritoneal dialysis solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peritoneal dialysis fluid (2.0 L)
Trial: 28660740
Drug: PEG-asparaginase (Oncaspar®)
RxNorm normalized name: Peg-asparaginase
DrugBank: Pegaspargase (DB00059)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: PEG-asparaginase (Oncaspar®) 1,000 IU/m²/dose, administered biweekly
Trial: 21171937
Drug: Testosterone (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testosterone (250 mg of testosterone enanthate every 4 weeks)
Trial: 18053317
Drug: Simvastatin (10-80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin (10-80 mg)
Trial: 14640465
Drug: Atorvastatin (10-80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin (10-80 mg)
Trial: 18053317
Drug: Ezetimibe and
RxNorm normalized name: Ezetimibe and Simvastatin Tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ezetimibe and statins (co-administration)
Trial: 12625376
Drug: DDAT exercise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DDAT exercise programme used daily at home
Trial: 12625376
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (same treatment at school, no DDAT exercise programme)
Trial: 1528786
Drug: Chloral hydrate
RxNorm normalized name: Chloral Hydrate
DrugBank: Chloral hydrate (DB01563)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chloral hydrate (CH) 25 mg/kg
Trial: 1528786
Drug: Chloral hydrate
RxNorm normalized name: Chloral Hydrate
DrugBank: Chloral hydrate (DB01563)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chloral hydrate (CH) 70 mg/kg
Trial: 22545212
Drug: Electrical muscle
RxNorm normalized name: ActivOn Joint & Muscle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electrical muscle stimulation (EMS) applied daily on vastus lateralis, vastus medialis, and peroneus longus of both lower extremities.
Trial: 21125816
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg entecavir dispersible tablets under fasted conditions
Trial: 21125816
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg entecavir dispersible tablets under fed conditions
Trial: 15502051
Drug: Oxymorphone IR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxymorphone IR 10 mg
Trial: 15502051
Drug: Oxymorphone IR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxymorphone IR 20 mg
Trial: 17692717
Drug: Oxycodone IR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone IR 15 mg
Trial: 15119915
Drug: Duloxetine 60
RxNorm normalized name: duloxetine 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duloxetine 60 mg q.d.
Trial: 9444883
Drug: Preliminary data
RxNorm normalized name: NO DATA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preliminary data showing 9 out of 10 patients improved with drug A
Trial: 9444883
Drug: Preliminary data
RxNorm normalized name: NO DATA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preliminary data showing 5 out of 10 patients improved with drug B
Trial: 16366815
Drug: Nicotine gum
RxNorm normalized name: Equate Nicotine Gum 4mg Starter Kit
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotine gum (0 mg)
Trial: 3174738
Drug: Nicotine gum
RxNorm normalized name: Equate Nicotine Gum 4mg Starter Kit
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotine gum (8 mg)
Trial: 27163830
Drug: Transdermal 17β-estradiol
RxNorm normalized name: 17β-estradiol
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal 17β-estradiol (50μg/day)
Trial: 27163830
Drug: Oral CEE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral CEE (0.45 mg/day)
Trial: 25183926
Drug: Levobupivacaine with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levobupivacaine with 1ml of isotonic saline (Group L)
Trial: 17647003
Drug: CCR5 inhibitor
RxNorm normalized name: Fibrinolysis inhibitor
DrugBank: Aprotinin (DB06692)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CCR5 inhibitor SCH351125
Trial: 10480473
Drug: Irbesartan monotherapy
RxNorm normalized name: Irbesartan
DrugBank: Irbesartan (DB01029)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Irbesartan monotherapy (0, 37.5, 100, and 300 mg)
Trial: 10480473
Drug: HCTZ monotherapy
RxNorm normalized name: Hydrochlorothiazide
DrugBank: Hydrochlorothiazide (DB00999)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: HCTZ monotherapy (0, 6.25, 12.5, and 25 mg)
Trial: 1747725
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose alpha-2b interferon (10 x 10(6) IU)
Trial: 1747725
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose alpha-2b interferon (100 x 10(6) IU)
Trial: 27307305
Drug: broad-spectrum antibiotics
RxNorm normalized name: Sentinel Spectrum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: broad-spectrum antibiotics (ciprofloxacin, vancomycin and metronidazole) for 7 days
Trial: 27307305
Drug: broad-spectrum antibiotics
RxNorm normalized name: Sentinel Spectrum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: broad-spectrum antibiotics
Trial: 26308780
Drug: Mobile health
RxNorm normalized name: Healthy Mama
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mobile health intervention for medication adherence and blood pressure control (3-month duration)
Trial: 24436453
Drug: Vaginally applied
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vaginally applied tenofovir gel
Trial: 19023644
Drug: Methylprednisolone (MTP)
RxNorm normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylprednisolone (MTP) 40 mg
Trial: 19023644
Drug: Triamcinolone (TMC)
RxNorm normalized name: Triamcinolone
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Triamcinolone (TMC) 40 mg
Trial: 15138948
Drug: Intervention hospitals
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intervention hospitals with sequential directed education and personalized feedback strategies
Trial: 10867040
Drug: 5.0 g/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5.0 g/d HPMC in 240 mL of orange drink taken between meals
Trial: 10867040
Drug: 5.0 g/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5.0 g/d HPMC in 240 mL of orange drink taken with meals
Trial: 2859136
Drug: Triazolam (0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triazolam (0.25 mg) + Ethanol (800 to 950 mg/L)